749 related articles for article (PubMed ID: 322910)
1. Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes.
Parsons RL
Clin Pharmacokinet; 1977; 2(1):45-60. PubMed ID: 322910
[TBL] [Abstract][Full Text] [Related]
2. Gut-thyroid interrelationships.
Miller LJ; Gorman CA; Go VL
Gastroenterology; 1978 Nov; 75(5):901-11. PubMed ID: 359404
[No Abstract] [Full Text] [Related]
3. Drugs, diseases and altered gastric emptying.
Nimmo WS
Clin Pharmacokinet; 1976; 1(3):189-203. PubMed ID: 797497
[TBL] [Abstract][Full Text] [Related]
4. Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulations.
Lennernäs H
Mol Pharm; 2009; 6(5):1429-40. PubMed ID: 19655809
[TBL] [Abstract][Full Text] [Related]
5. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S
Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
[TBL] [Abstract][Full Text] [Related]
6. Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications.
Gubbins PO; Bertch KE
Clin Pharmacokinet; 1991 Dec; 21(6):431-47. PubMed ID: 1782738
[TBL] [Abstract][Full Text] [Related]
7. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of drugs: the digoxin dilemma.
Greenblatt DJ; Smith TW; Koch-Weser J
Clin Pharmacokinet; 1976; 1(1):36-51. PubMed ID: 797491
[TBL] [Abstract][Full Text] [Related]
9. Drug absorption in celiac disease.
Tran TH; Smith C; Mangione RA
Am J Health Syst Pharm; 2013 Dec; 70(24):2199-206. PubMed ID: 24296842
[TBL] [Abstract][Full Text] [Related]
10. Simulating the postprandial stomach: physiological considerations for dissolution and release testing.
Koziolek M; Garbacz G; Neumann M; Weitschies W
Mol Pharm; 2013 May; 10(5):1610-22. PubMed ID: 23506381
[TBL] [Abstract][Full Text] [Related]
11. [Clinical studies of pediatric malabsorption syndromes].
Hosoyamada T
Fukuoka Igaku Zasshi; 2006 Nov; 97(11):322-50. PubMed ID: 17228786
[TBL] [Abstract][Full Text] [Related]
12. Drug absorption in gastrointestinal disease and surgery.
Gubbins PO; Bertch KE
Pharmacotherapy; 1989; 9(5):285-95. PubMed ID: 2682550
[TBL] [Abstract][Full Text] [Related]
13. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
[TBL] [Abstract][Full Text] [Related]
14. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
[TBL] [Abstract][Full Text] [Related]
15. Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in the stomach, duodenum and jejunum.
Jobin G; Cortot A; Godbillon J; Duval M; Schoeller JP; Hirtz J; Bernier JJ
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):97S-105S. PubMed ID: 4005135
[TBL] [Abstract][Full Text] [Related]
16. Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract.
Masaoka Y; Tanaka Y; Kataoka M; Sakuma S; Yamashita S
Eur J Pharm Sci; 2006 Nov; 29(3-4):240-50. PubMed ID: 16876987
[TBL] [Abstract][Full Text] [Related]
17. Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption of Ionizable Drugs.
Hens B; Tsume Y; Bermejo M; Paixao P; Koenigsknecht MJ; Baker JR; Hasler WL; Lionberger R; Fan J; Dickens J; Shedden K; Wen B; Wysocki J; Loebenberg R; Lee A; Frances A; Amidon G; Yu A; Benninghoff G; Salehi N; Talattof A; Sun D; Amidon GL
Mol Pharm; 2017 Dec; 14(12):4281-4294. PubMed ID: 28737409
[TBL] [Abstract][Full Text] [Related]
18. Normal and abnormal intestinal absorption by humans.
Heizer WD
Environ Health Perspect; 1979 Dec; 33():101-6. PubMed ID: 540610
[TBL] [Abstract][Full Text] [Related]
19. Effect of surfactants, gastric emptying, and dosage form on supersaturation of dipyridamole in an in vitro model simulating the stomach and duodenum.
Mitra A; Fadda HM
Mol Pharm; 2014 Aug; 11(8):2835-44. PubMed ID: 25025699
[TBL] [Abstract][Full Text] [Related]
20. Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1: oral solutions.
Thelen K; Coboeken K; Willmann S; Burghaus R; Dressman JB; Lippert J
J Pharm Sci; 2011 Dec; 100(12):5324-45. PubMed ID: 21993815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
